Marita Lipsanen‐Nyman

ORCID: 0000-0003-4959-2310
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Metabolism and Genetic Disorders
  • Genetic Syndromes and Imprinting
  • Prenatal Screening and Diagnostics
  • Glycogen Storage Diseases and Myoclonus
  • Epigenetics and DNA Methylation
  • Mitochondrial Function and Pathology
  • Dermatological and Skeletal Disorders
  • Genomic variations and chromosomal abnormalities
  • Diet and metabolism studies
  • Genetic Neurodegenerative Diseases
  • Connective tissue disorders research
  • Neurological and metabolic disorders
  • Nuclear Structure and Function
  • Neurogenetic and Muscular Disorders Research
  • Diabetes and associated disorders
  • Renal Diseases and Glomerulopathies
  • Growth Hormone and Insulin-like Growth Factors
  • Microtubule and mitosis dynamics
  • RNA regulation and disease
  • Neurological disorders and treatments
  • Cardiomyopathy and Myosin Studies
  • Neuroendocrine Tumor Research Advances
  • Peroxisome Proliferator-Activated Receptors
  • Genetic and Kidney Cyst Diseases
  • Neonatal Health and Biochemistry

University of Helsinki
2015-2024

Helsinki University Hospital
2015-2024

Helsinki Children's Hospital
2000-2020

Institute of Genetics
2018

Children's Hospital
2010-2013

University of Bergen
1998

The salivary α-amylase locus (AMY1) is located in a highly polymorphic multi allelic copy number variable chromosomal region. A recent report identified an association between AMY1 numbers and BMI common obesity. present study investigated the relationship number, serum amylase childhood-onset obesity.Sixty-one subjects with history of obesity (mean age 19.1 years, 54% males) 71 matched controls (19.8 yrs, 45% were included. All anthropometric measures greater obese; their mean was 40 kg/m2...

10.1371/journal.pone.0131883 article EN cc-by PLoS ONE 2015-07-01

Context: The H19 imprinting control region (ICR), located on chromosome 11p15.5, has been reported hypomethylated in 20–65% of Silver-Russell syndrome (SRS) patients. Objective: We investigated the methylation status 11p15.5 ICRs SRS patients and children born small for gestational age (SGA) to clarify relationship between phenotype status. Methods: performed screens KCNQ1OT1 42 patients, including seven maternal uniparental disomy 7 90 SGA without SRS. Clinical data were evaluated from...

10.1210/jc.2008-1805 article EN The Journal of Clinical Endocrinology & Metabolism 2008-11-19

Silver-Russell syndrome (SRS, OMIM 180860) features fetal and postnatal growth restriction variable dysmorphisms. Genetic epigenetic aberrations on chromosomes 7 11 are commonly found in SRS. However, a large fraction of SRS cases remain with unknown genetic aetiology.22 patients diagnosis (10 H19 hypomethylation 12 molecular aetiology) their parents were studied the Affymetrix 250K Sty microarray. Several analytical approaches used to identify genomic such as copy number changes (CNCs),...

10.1136/jmg.2009.069427 article EN Journal of Medical Genetics 2009-09-14

Context: Observations in rodents suggest that osteocalcin (OC) participates glucose metabolism. Based on human studies, it remains unclear whether circulating OC is simply a bone turnover marker (BTM) or also mediator interactions between the skeleton and homeostasis. Objective: The objective of study was to determine responses BTMs, including OC, oral tolerance test (OGTT) case-control setting. Design Patients: Thirty-four normoglycemic young adults [mean age 19 y (SD 2.3)] with severe...

10.1210/jc.2013-3097 article EN The Journal of Clinical Endocrinology & Metabolism 2014-03-10
Hyoungjun Ham Huie Jing Ian T. Lamborn M. Kober Alexey Koval and 95 more Yamina A. Berchiche David E. Anderson Kirk M. Druey Judith N. Mandl Bertrand Isidor Carlos R. Ferreira Alexandra F. Freeman Sundar Ganesan Meliha Karsak Peter Mustillo Juliana Teo Zarazuela Zolkipli‐Cunningham Nicolas Chatron François Lecoquierre Andrew J. Oler Jana Pachlopnik Schmid Douglas B. Kuhns Xuehua Xu Fabian Hauck Waleed Al–Herz Matias Wagner Paulien A. Terhal Mari Muurinen Vincent Barlogis Phillip Cruz Jeffrey J. Danielson Helen Stewart Petra Loid Sebastian Rading Boris Keren Rolph Pfundt Kol A. Zarember Katharina Vill Lorraine Potocki Kenneth N. Olivier Gaëtan Lesca Laurence Faivre Melanie Wong Anne Puel Janet Chou Maud Tusseau Niki M. Moutsopoulos Helen Matthews Cas Simons Ryan J. Taft Ariane Soldatos Etienne Masle‐Farquhar Stefania Pittaluga Robert Brink Danielle Fink Heidi H. Kong Juraj Kabát Woo Sung Kim Tatjana Bierhals Kazuyuki Meguro Amy P. Hsu Jingwen Gu Jennifer Stoddard Benito Banos-Pinero Maria A. Slack Giampaolo Trivellin Benoît Mazel Maarja Soomann Samuel T. Li Val J. Watts Constantine A. Stratakis Maria F. Rodriguez-Quevedo Ange‐Line Bruel Marita Lipsanen‐Nyman Paul Saultier Rashmi Jain Daphné Lehalle Daniel Torres Kathleen E. Sullivan S. Barbarot Axel Neu Yannis Duffourd Morgan Similuk Kirsty McWalter Pierre Blanc Stéphane Bézieau Tian Jin Raif S. Geha Jean‐Laurent Casanova Outi Mäkitie Christian Kubisch Patrick Edery John Christodoulou Ronald N. Germain Christopher C. Goodnow Thomas P. Sakmar Daniel D. Billadeau Sébastien Küry Vladimir L. Katanaev Yu Zhang

Humans with monogenic inborn errors responsible for extreme disease phenotypes can reveal essential physiological pathways. We investigated germline mutations in GNAI2 , which encodes G αi2 a key component heterotrimeric protein signal transduction usually thought to regulate adenylyl cyclase–mediated cyclic adenosine monophosphate (cAMP) production. Patients activating had clinical presentations that included impaired immunity. Mutant cell migration and augmented responses T receptor (TCR)...

10.1126/science.add8947 article EN Science 2024-09-19

Two Finnish cohorts, comprising 56 children with severe early-onset obesity (relative weight for height greater than or equal to +70% before age 10) and 252 morbidly obese adults (body mass index, ≥40 kg/m2), were screened melanocortin-4 receptor (MC4R) mutations. We identified a pathogenic mutation (S127L) in one child, causing obesity. describe the phenotype of this particular first time. also novel (I226T) polymorphism coding two new variations (−439delGC 1059C>T) outside region MC4R...

10.1210/jc.2003-031182 article EN The Journal of Clinical Endocrinology & Metabolism 2004-02-01

The aims of this study were to evaluate the efficacy and safety different doses growth hormone (GH) treatment in prepubertal short children born small-for-gestational-age (SGA). Forty-eight SGA from Sweden, Finland, Denmark Norway randomly allocated three groups: a control group 12 received no for 2 y, one was treated with GH at 0.1 IU/kg/d (n= 16), 0.2 20). In total 42 completed y follow-up, 24 groups 3 treatment. Their mean (SD) age start 4.69 (1.61) their height -3.16 (0.70) standard...

10.1080/08035259850157282 article EN Acta Paediatrica 1998-04-19

Familial growth hormone deficiency provides an opportunity to identify new genetic causes of short stature. Here we combine linkage analysis with whole-genome resequencing in patients and maternally inherited gingival fibromatosis. We report that from three unrelated families harbor either two missense mutations, c.347G>T p.(Arg116Leu) or c.1106C>T p.(Pro369Leu), KCNQ1, a gene previously implicated the long QT interval syndrome. Kcnq1 is expressed hypothalamic GHRH neurons pituitary...

10.1038/s41467-017-01429-z article EN cc-by Nature Communications 2017-10-30

Context: The hypothalamic circuit has an essential role in the regulation of appetite and energy expenditure. Pathogenic variants genes involved leptin–melanocortin pathway, including melanocortin-4-receptor (MC4R), have been associated with monogenic obesity. Objective: To determine rate spectrum rare melanocortin pathway or development patients severe early-onset obesity (height-adjusted weight >60% before age 10 years). Methods: We used a custom-made targeted exome sequencing panel to...

10.3389/fendo.2020.00081 article EN cc-by Frontiers in Endocrinology 2020-02-21

The aims of this study were to evaluate the efficacy and safety different doses growth hormone (GH) treatment in prepubertal short children born small‐for‐gestational‐age (SGA). Forty‐eight SGA from Sweden, Finland, Denmark Norway randomly allocated three groups: a control group 12 received no for 2 y, one was treated with GH at 0.1 IU/kg/d ( n = 16), 0.2 20). In total 42 completed y follow‐up, 24 groups 3 treatment. Their mean (SD) age start 4.69 (1.61) their height ‐3.16 (0.70) standard...

10.1111/j.1651-2227.1998.tb01434.x article EN Acta Paediatrica 1998-03-01

The aim was to evaluate whether the metabolic syndrome associates with other endocrinopathies observed after allogeneic stem cell transplantation (SCT) in childhood. Thirty-one SCT long-term survivors, transplanted for leukemia (n=26) or nonmalignant hematologic diseases (n=5) were evaluated by oral glucose tolerance test and assessment of serum lipids at a median age 15 (range 7 34) years. Hyperinsulinemia, hypertriglyceridemia, abdominal obesity required diagnosis syndrome. Growth hormone...

10.1097/mph.0b013e3180f61b67 article EN Journal of Pediatric Hematology/Oncology 2007-08-01

Mulibrey nanism (MUL) is a monogenic disorder with prenatal-onset growth failure, typical clinical characteristics, cardiopathy and tendency for metabolic syndrome. It caused by recessive mutations in the TRIM37 gene encoding peroxisomal protein ubiquitin-ligase activity. In this work, frequency pathology of malignant benign tumours were analysed national cohort 89 Finnish MUL patients aged 0.7-76 years. The subjects had radiological evaluation, histological immunohistocemical analyses on...

10.1002/path.2538 article EN The Journal of Pathology 2009-02-10

DNA methylation is a hallmark of genomic imprinting and differentially methylated regions (DMRs) are found near in imprinted genes. Imprinted genes expressed only from the maternal or paternal allele their normal balance can be disrupted by uniparental disomy (UPD), inheritance both chromosomes chromosome pair exclusively either mother father. Maternal UPD for 7 (matUPD7) results Silver-Russell syndrome (SRS) with typical features growth retardation, but no gene has been conclusively...

10.4161/epi.27160 article EN Epigenetics 2013-11-18

TRIM37 is an E3 ubiquitin ligase mutated in Mulibrey nanism, a disease with impaired organ growth and increased tumor formation. depletion from tissue culture cells results supernumerary foci bearing the centriolar protein Centrin. Here, we characterize these assemblies (Cenpas) to uncover mechanism of action TRIM37. We find that atypical de novo assembly pathway can generate Cenpas act as microtubule-organizing centers (MTOCs), including patient cells. Correlative light electron microscopy...

10.7554/elife.62640 article EN cc-by eLife 2021-01-25

Mulibrey nanism is a rare inherited disease characterized by growth failure and multiorgan manifestations, including constrictive pericarditis. Its long-term course, the results of pericardiectomy, details myocardial involvement have not been reported previously.We studied 49 patients (26 men) born before 1985 followed for up to 25 years. By 1999, (51%) had developed congestive heart (CHF), 19 (39%) undergone pericardiectomy pericarditis, 10 (22%) died cardiac causes, 5 (10%) noncardiac...

10.1161/01.cir.0000070949.76608.e2 article EN Circulation 2003-05-20

Epigenetic studies, such as the measurement of DNA methylation, are important in investigation syndromes influenced by imprinted genes. Quick and accurate quantification methylation at genes can be appreciable diagnostic aid.We first digested genomic with methylation-sensitive restriction enzymes used without digestion a control nonmethylated lambda an internal for efficiency. We then performed quantitative real-time PCR analyses 6 unique assays to investigate 4 imprinting regions on...

10.1373/clinchem.2007.098491 article EN Clinical Chemistry 2008-01-18

Mulibrey nanism is an autosomal recessive prenatal-onset growth disorder of unknown pathogenesis. The main clinical features are pre- and postnatal failure, characteristic dysmorphic craniofacial features, heart disease, hepatomegaly. Five truncating mutations in the TRIM37 gene have previously been reported patients. protein encodes a novel function. It contains tripartite motif (TRIM, also denoted RING-B-box-Coiled-coil or RBCC domain) TRAF (tumor necrosis factor-receptor associated...

10.1002/humu.9233 article EN Human Mutation 2004-03-31

ABSTRACT Mulibrey nanism (MUL) is a rare autosomal recessive multi-organ disorder characterized by severe prenatal-onset growth failure, infertility, cardiopathy, risk for tumors, fatty liver, and type 2 diabetes. MUL caused loss-of-function mutations in TRIM37, which encodes an E3 ubiquitin ligase belonging to the tripartite motif (TRIM) protein family having both peroxisomal nuclear localization. We describe congenic Trim37 knock-out mouse (Trim37−/−) model MUL. Trim37−/− mice were viable...

10.1242/bio.016246 article EN cc-by Biology Open 2016-04-04
Coming Soon ...